Successful use of intravitreal rituximab as salvage therapy for relapsed vitreoretinal lymphoma
{{output}}
Purpose: To describe the outcomes, response patterns, and complications of intravitreal rituximab (IVR) in eyes with relapsed vitreoretinal lymphoma (VRL) despite previous treatment with ocular radiotherapy (EBRT). ... ...
